1474 / 1816
RAPCHEM study (
NCT01279304
)
cT1-2N1 ( > 3 suspicious nodes excluded), treated with PST
Inclusion 2011-2015: 860 patients.
Preliminary analysis March 2016:
Boersma et al, poster EBCC 2016
•
Data maturing to reach at least 5 year of follow-up…